Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)

Clémence Baudin   ¹ , PhD ;   Charlotte Lussey-Lepoutre   ^{2, 3} , MD, PhD, Prof Dr ;   Alice Bressand   ⁴ ;   Camille Buffet   ⁵ , MD ;   Fabrice Menegaux   ^{5, 6} , MD, Prof Dr ;   Marine Soret   ^{6, 7} , MD ;   David Broggio   ⁸ , PhD ;   Céline Bassinet   ⁹ , PhD ;   Christelle Huet   ⁹ , PhD ;   Gemma Armengol   ¹⁰ , PhD, Prof Dr ;   Laurence Leenhardt   ⁵ , MD, Prof Dr ;   Marie-Odile Bernier   ¹ , MD, PhD

¹ Ionizing Radiation Epidemiology Laboratory, Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France

² Department of Nuclear Medicine, Sorbonne University, Pitié-Salpêtrière Hospital APHP, Paris, France

³ Equipe Labellisée par la Ligue Contre le Cancer, Paris Research Center Cardiovascular, Institut National de la Santé et de la Recherche Médicale, University Paris City, Paris, France

⁴ Amarexia France, Paris, France

⁵ Thyroid and Endocrine Tumors Unit, Groupe de Recherche Clinique Tumeurs Thyroïdiennes no. 16, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

⁶ Department of General and Endocrine Surgery, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France

⁷ Biomedical Imaging Laboratory, French National Centre for Scientific Research, Institut National de la Santé et de la Recherche Médicale, Sorbonne University, Paris, France

⁸ Internal Dose Assessment Laboratory, Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France

⁹ Ionizing Radiation Dosimetry Laboratory, Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France

¹⁰ Department of Animal Biology, Plant Biology and Ecology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain